Ken Paterson

1.3k total citations
47 papers, 777 citations indexed

About

Ken Paterson is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nephrology. According to data from OpenAlex, Ken Paterson has authored 47 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Ken Paterson's work include Diabetes Management and Research (15 papers), Diabetes Treatment and Management (10 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). Ken Paterson is often cited by papers focused on Diabetes Management and Research (15 papers), Diabetes Treatment and Management (10 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). Ken Paterson collaborates with scholars based in United Kingdom, Sweden and Italy. Ken Paterson's co-authors include Nicholas J. Talley, Philip Boyce, A C MacCuish, Nicola Joss, Sandra MacRury, David H. Lawson, Thomas M. Donnelly, Jennifer M. Gray, A. S. Hutchison and J. M. Boulton‐Jones and has published in prestigious journals such as Diabetes Care, Journal of Clinical Pathology and Clinica Chimica Acta.

In The Last Decade

Ken Paterson

45 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Paterson United Kingdom	16	275	119	113	112	107	47	777
Nilka Ríos-Burrows United States	5	288 1.0×	25 0.2×	71 0.6×	80 0.7×	46 0.4×	5	729
Ute Amann Germany	16	126 0.5×	64 0.5×	286 2.5×	124 1.1×	76 0.7×	42	749
Juan F. Macías Núñez Spain	18	55 0.2×	50 0.4×	127 1.1×	127 1.1×	122 1.1×	83	906
Ji Lin United States	9	395 1.4×	54 0.5×	91 0.8×	102 0.9×	57 0.5×	13	778
S. Cohen United States	17	57 0.2×	43 0.4×	198 1.8×	280 2.5×	71 0.7×	44	854
Juana Carretero‐Gómez Spain	15	258 0.9×	22 0.2×	110 1.0×	122 1.1×	73 0.7×	95	799
A Snaith United Kingdom	8	470 1.7×	18 0.2×	46 0.4×	232 2.1×	30 0.3×	14	815
Turgay Arınsoy Türkiye	16	135 0.5×	15 0.1×	216 1.9×	172 1.5×	83 0.8×	79	914
Jian Ying United States	18	195 0.7×	11 0.1×	115 1.0×	244 2.2×	97 0.9×	55	1.1k
Chi Wang China	19	132 0.5×	13 0.1×	143 1.3×	95 0.8×	83 0.8×	55	873

Countries citing papers authored by Ken Paterson

Since Specialization

Citations

This map shows the geographic impact of Ken Paterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Paterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Paterson more than expected).

Fields of papers citing papers by Ken Paterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Paterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Paterson. The network helps show where Ken Paterson may publish in the future.

Co-authorship network of co-authors of Ken Paterson

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Paterson. A scholar is included among the top collaborators of Ken Paterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Paterson. Ken Paterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Godman, Brian, et al.. (2012). Improving the managed entry of new medicines: sharing experiences across Europe. Expert Review of Pharmacoeconomics & Outcomes Research. 12(4). 439–441. 40 indexed citations

Dear, James W., et al.. (2007). Scottish Medicines Consortium. Scottish Medical Journal. 52(3). 3 indexed citations

Joss, Nicola, Rishi Patel, Ken Paterson, et al.. (2007). Anaemia is common and predicts mortality in diabetic nephropathy. QJM. 100(10). 641–647. 28 indexed citations

Harrison, Mark, et al.. (2006). Oxford practice grammar: basic. Oxford University Press eBooks.

Macfarlane, David P., Ken Paterson, & Miles Fisher. (2006). Oral antidiabetic agents as cardiovascular drugs. Diabetes Obesity and Metabolism. 9(1). 23–30. 24 indexed citations

Joss, Nicola, et al.. (2004). Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy. QJM. 97(4). 219–227. 29 indexed citations

Sandham, W.A., et al.. (1998). Blood glucose prediction for diabetes therapy using a recurrent artificial neural network. Research Repository (Kingston University London). 1–4. 17 indexed citations

Beresford, J., D G Colin‐Jones, M. J. S. Langman, et al.. (1998). Postmarketing surveillance of the safety of cimetidine: 15-year mortality report. Pharmacoepidemiology and Drug Safety. 7(5). 319–322. 9 indexed citations

Fox, J. G., et al.. (1995). Glomerular Charge Selectivity in Type 1 (Insulin‐dependent) Diabetes Mellitus. Diabetic Medicine. 12(5). 387–391. 7 indexed citations

10.

Paterson, Ken, et al.. (1993). Estimating urinary albumin excretion rate of diabetic patients in clinical practice.. BMJ. 306(6876). 493.2–494. 21 indexed citations

11.

Paterson, Ken. (1993). Population Screening for Diabetes Mellitus. Diabetic Medicine. 10(8). 777–781. 25 indexed citations

12.

Gordon, Derek, et al.. (1993). Psychological Factors and their Relationship to Diabetes Control. Diabetic Medicine. 10(6). 530–534. 16 indexed citations

13.

Gordon, Derek, C. G. Semple, & Ken Paterson. (1991). Do Different Frequencies of Self‐monitoring of Blood Glucose Influence Control in Type 1 Diabetic Patients?. Diabetic Medicine. 8(7). 679–682. 16 indexed citations

14.

MacRury, Sandra, Eric S Kilpatrick, Ken Paterson, & Marek H Dominiczak. (1991). Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1in type 2 (non-insulin dependent) diabetic patients. Clinica Chimica Acta. 199(1). 51–58. 3 indexed citations

15.

Quin, John, et al.. (1990). Metastatic Basal Cell Carcinoma Causing Cord Compression. Scottish Medical Journal. 35(3). 85–85. 7 indexed citations

16.

Paterson, Ken, I. W. Campbell, Sandra MacRury, D. G. Gilmour, & A C MacCuish. (1988). Management of Diabetes Resistant to Subcutaneous Insulin with Intravenous Insulin via an Implanted Infusion Pump. Scottish Medical Journal. 33(2). 239–243. 4 indexed citations

17.

Hutchison, A. S. & Ken Paterson. (1988). Collecting Urine for Microalbumin Assay. Diabetic Medicine. 5(6). 527–532. 29 indexed citations

18.

Dominiczak, Marek H, et al.. (1988). Long-Term Performance of the Fructosamine Assay. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 25(6). 627–633. 9 indexed citations

19.

Paterson, Ken, C. B. Lunan, & A.C. MacCuish. (1985). Severe transient nephrotic syndrome in diabetic pregnancy.. BMJ. 291(6509). 1612–1612. 3 indexed citations

20.

COHEN, H. N., Ken Paterson, A Wallace, et al.. (1984). DISSOCIATION OF ADRENARCHE AND GONADARCHE IN DIABETES MELLITUS. Clinical Endocrinology. 20(6). 717–724. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact